
Kyverna Therapeutics, Inc.
USD9.13
+0.35 (+3.99%)
CEO
Warner Biddle
IPO Date
2024-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.78
Prev. Close
$8.78
Day Low
$8.65
Day High
$9.19
52W Low
$2.52
52W High
$13.67
Market Cap
$0.40B
Volume
0.38M
| 23 Apr 2026 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 16 Dec 2025 | Wells Fargo | Overweight | Overweight | maintain |
| 4 Dec 2025 | Morgan Stanley | Overweight | Overweight | maintain |
| 30 Oct 2025 | Wells Fargo | Overweight | Overweight | maintain |
| 27 Oct 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 8 Oct 2025 | Wells Fargo | Overweight | Overweight | maintain |
| 29 Aug 2025 | HC Wainwright & Co. | Buy | Buy | maintain |